John A Carucci Selected Research

John A Carucci Research Topics

Disease

20	Neoplasms (Cancer) 02/2024 - 04/2006
18	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 04/2006
6	Melanoma (Melanoma, Malignant) 11/2023 - 10/2002
5	Skin Neoplasms (Skin Cancer) 10/2021 - 04/2002
5	Basal Cell Carcinoma (Rodent Ulcer) 04/2020 - 04/2002
4	Merkel Cell Carcinoma 03/2024 - 10/2023
3	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2011 - 05/2007
2	Actinic Keratosis 10/2021 - 02/2013
2	Carcinoma (Carcinomatosis) 04/2020 - 01/2013
2	Inflammation (Inflammations) 09/2011 - 06/2010
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Postoperative Pain 03/2020
1	Testicular Neoplasms (Testicular Cancer) 01/2020
1	Cicatrix (Scar) 12/2014
1	Alopecia (Baldness) 12/2014
1	Tics (Tic) 07/2014
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 10/2013
1	Starvation 01/2013
1	Atopic Dermatitis (Atopic Eczema) 11/2008
1	Hyperplasia 04/2006

Drug/Important Bio-Agent (IBA)

5	Interleukin-22 (IL-22)IBA 01/2018 - 11/2008
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 11/2008
3	AntigensIBA 01/2020 - 09/2011
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018 - 01/2016
3	CytokinesIBA 06/2012 - 05/2007
2	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 07/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2008
2	interleukin-22 receptor (IL-22R)IBA 01/2018 - 01/2013
2	LigandsIBA 04/2017 - 05/2007
2	ChemokinesIBA 09/2011 - 05/2007
2	Interleukin-17 (Interleukin 17)IBA 06/2010 - 11/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 05/2007
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2009 - 05/2007
1	Acitretin FDA Link 10/2021
1	Immune Checkpoint InhibitorsIBA 04/2020
1	Toll-Like Receptor AgonistsIBA 04/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2020
1	Opioid Analgesics (Opioids)IBA 03/2020
1	Ibuprofen (Motrin)FDA LinkGeneric 03/2020
1	Oxycodone (Oxycontin)FDA LinkGeneric 03/2020
1	CollagenIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Cyclin EIBA 01/2020
1	ruxolitinibIBA 01/2018
1	pembrolizumabIBA 04/2017
1	GlucocorticoidsIBA 12/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014
1	SOXB1 Transcription FactorsIBA 07/2014
1	Anaplastic Lymphoma KinaseIBA 12/2013
1	Capecitabine (Xeloda)FDA Link 10/2013
1	HhAntag691IBA 10/2013
1	Cetuximab (Erbitux)FDA Link 10/2013
1	Sirolimus (Rapamycin)FDA Link 09/2013
1	Vascular Endothelial Growth Factor CIBA 01/2011
1	Prostaglandins EIBA 10/2009
1	HLA-DR Antigens (HLA-DR)IBA 10/2009
1	Interleukin-23 (Interleukin 23)IBA 11/2008
1	ElafinIBA 11/2008
1	Lipocalin-2IBA 11/2008
1	Interleukin-12 (IL 12)IBA 10/2007
1	Interleukin-10 (Interleukin 10)IBA 10/2007
1	InterferonsIBA 10/2007
1	Interleukin-4 (Interleukin 4)IBA 10/2007
1	Thymic Stromal LymphopoietinIBA 05/2007
1	Keratin-16 (Keratin 16)IBA 04/2006
1	OligonucleotidesIBA 04/2006
1	Wnt-5a ProteinIBA 04/2006
1	DefensinsIBA 04/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2006
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2006
1	Cell Adhesion MoleculesIBA 04/2006
1	pleiotrophin (HARP)IBA 04/2006
1	STAT1 Transcription FactorIBA 04/2006
1	Carcinoembryonic AntigenIBA 04/2006

Therapy/Procedure

15	Mohs Surgery (Mohs' Micrographic Surgery) 03/2024 - 04/2002
6	Therapeutics 02/2024 - 10/2013
4	Immunotherapy 02/2024 - 06/2012
2	Dermatologic Surgical Procedures 04/2017 - 12/2016
2	Lasers (Laser) 02/2013 - 01/2011
1	Cryotherapy (Therapy, Cold) 10/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2020
1	Adjuvant Radiotherapy 01/2020
1	Radiotherapy 04/2017
1	Injections 12/2014
1	Transplantation 09/2013